Molecular targeted therapies for pediatric atypical teratoid/rhabdoid tumors
ABSTRACT Atypical teratoid/rhabdoid tumors (AT/RTs) are lethal central nervous system tumors, which are primarily diagnosed in infants. Current treatments for AT/RTs include surgery, radiotherapy, and chemotherapy; these treatments have poor prognoses and challenging side effects. The pivotal geneti...
Main Authors: | Chang Zhang, Hao Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | Pediatric Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1002/ped4.12325 |
Similar Items
-
A rare case of multifocal atypical teratoid rhabdoid tumor
by: Nguyen Minh Duc, MD
Published: (2023-02-01) -
Infants and Newborns with Atypical Teratoid Rhabdoid Tumors (ATRT) and Extracranial Malignant Rhabdoid Tumors (eMRT) in the EU-RHAB Registry: A Unique and Challenging Population
by: Karolina Nemes, et al.
Published: (2022-04-01) -
Large intracranial atypical teratoid / rhabdoid tumor with preserved INI-1 expression: A case report
by: Zhenwei Lu, et al.
Published: (2023-09-01) -
Atypical Teratoid/Rhabdoid Tumor in Taiwan: A Nationwide, Population-Based Study
by: Yen-Lin Liu, et al.
Published: (2022-01-01) -
Atypical Teratoid Rhabdoid Tumours Are Susceptible to Panobinostat-Mediated Differentiation Therapy
by: Wai C. Chong, et al.
Published: (2021-10-01)